BioCryst to Present at Upcoming Investor Conference
BioCryst Pharmaceuticals (Nasdaq: BCRX) announced its upcoming presentation at the Cantor Global Healthcare Conference in New York. The presentation is scheduled for Thursday, September 4, 2025, at 9:45 a.m. ET. Investors can access both the live audio webcast and replay through the Investors & Media section of BioCryst's website.
BioCryst Pharmaceuticals (Nasdaq: BCRX) ha annunciato la presentazione prevista alla Cantor Global Healthcare Conference di New York. La presentazione 猫 programmata per gioved矛 4 settembre 2025 alle 9:45 (ET). Gli investitori potranno seguire la diretta audio via webcast e successivamente la replica nella sezione Investitori & Media del sito di BioCryst.
BioCryst Pharmaceuticals (Nasdaq: BCRX) anunci贸 su pr贸xima presentaci贸n en la Cantor Global Healthcare Conference en Nueva York. La presentaci贸n est谩 programada para el jueves 4 de septiembre de 2025 a las 9:45 a. m. ET. Los inversores podr谩n acceder tanto a la retransmisi贸n de audio en directo como a la repetici贸n a trav茅s de la secci贸n Investors & Media del sitio web de BioCryst.
BioCryst Pharmaceuticals (Nasdaq: BCRX)臧� 雺挫殨鞐愳劀 鞐措Μ電� Cantor Global Healthcare Conference鞐愳劀 鞓堨爼霅� 氚滍憸毳� 氚滍憸頄堨姷雼堧嫟. 氚滍憸電� 2025雲� 9鞗� 4鞚� 氇╈殧鞚� 鞓れ爠 9鞁� 45攵�(ET)鞐� 鞓堨爼霅橃柎 鞛堨姷雼堧嫟. 韴瀽鞛愲摛鞚� BioCryst 鞗轨偓鞚错姼鞚� Investors & Media 靹轨厴鞚� 韱淀暣 鞓る敂鞓� 鞗轨簮鞀ろ姼 鞁れ嫓臧� 欷戧硠 氚� 雼れ嫓氤搓赴鞐� 鞝戩啀頃� 靾� 鞛堨姷雼堧嫟.
BioCryst Pharmaceuticals (Nasdaq: BCRX) a annonc茅 sa pr茅sentation prochaine 脿 la Cantor Global Healthcare Conference 脿 New York. La pr茅sentation est pr茅vue le jeudi 4 septembre 2025 脿 9h45 (ET). Les investisseurs pourront 茅couter la diffusion audio en direct et le replay via la section Investors & Media du site web de BioCryst.
BioCryst Pharmaceuticals (Nasdaq: BCRX) hat seine bevorstehende Pr盲sentation auf der Cantor Global Healthcare Conference in New York angek眉ndigt. Die Pr盲sentation ist f眉r Donnerstag, den 4. September 2025, um 9:45 Uhr ET angesetzt. Investoren k枚nnen sowohl den Live-Audio-Webcast als auch die Aufzeichnung 眉ber den Bereich Investors & Media auf der Website von BioCryst abrufen.
- None.
- None.
RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- (狈补蝉诲补辩:听BCRX) today announced that the company plans to present at the Cantor Global Healthcare Conference in New York on Thursday, September 4, 2025, at 9:45 a.m. ET.
The link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst鈥檚 website at .
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO庐 (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit or follow us on .
BCRXW
Contact:
Investors:
[email protected]
Media:
[email protected]
FAQ
When is BioCryst (BCRX) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access BioCryst's (BCRX) Cantor Conference presentation?
Where is the 2025 Cantor Global Healthcare Conference being held?
What time is BioCryst's (BCRX) presentation at the Cantor Conference?
